Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics - Open, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 21 Feb 2019

#HealthEconJA Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence…